Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review
Pain Management Nursing · 2026
DOI: 10.1016/j.pmn.2025.06.010 ↗Kurz gefasst
Scoping Review in der Zeitschrift Pain Management Nursing, 2026. Verfasst von Simone B Jackson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biobehavioral Nursing Science, University of Florida, College of Nursing, Gainesville, FL. Electronic address: si.jackson@ufl.edu. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Chronic Pain, Pain Management, Medical Marijuana. Die Arbeit nennt 56 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
PURPOSE: The purposes of this scoping review were to: (1) systematically evaluate the literature on the types and effectiveness of cannabis and cannabinoids for pain management in adults with sickle cell disease (SCD), (2) assess the effect of cannabis and cannabinoids on pain outcomes, and (3) identify research gaps. DESIGN: Systematic scoping review. METHODS: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines, relevant studies were identified across PubMed, CINAHL, and Cannakeys databases. Inclusion criteria were studies involving medical and recreational cannabis use in adult SCD patients addressing pain management. Exclusion criteria included studies on pediatric populations, non-English publications, or case reports. RESULTS: Of 369 articles, 12 met inclusion criteria (one clinical trial, two reviews, seven observational, one mixed-methods, and one qualitative study), revealing mixed but generally positive evidence on cannabinoid effectiveness. While some studies indicated reduced pain scores with inhaled cannabis, results varied for other pain outcomes, such as hospitalizations for vaso-occlusive crises, and raised safety concerns, particularly with synthetic cannabinoids. CONCLUSIONS: Cannabinoids may help manage SCD pain, though evidence remains mixed. No studies showed exacerbation of SCD symptoms, but safety concerns warrant careful use. CLINICAL IMPLICATIONS: The variability in outcomes underscores the need for personalized cannabis-based treatment plans and further research on standardized dosing and long-term safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biobehavioral Nursing Science, University of Florida, College of Nursing, Gainesville, FL. Electronic address: si.jackson@ufl.edu.
- Department of Biobehavioral Nursing Science, University of Florida, College of Nursing, Gainesville, FL.
- Rutgers School of Nursing, Newark, NJ.
- Department of Epidemiology, University of Florida, College of Public Health and Health Professions & College of Medicine, Gainesville, FL.
- Department of Epidemiology, University of Florida, College of Public Health and Health Professions, Gainesville, FL.
Zitieren
APA
Jackson, S. B., Payton, I., Powell-Roach, K., Starkweather, A., Cook, R. L., Varma, D. S., Terry, E. L., & Booker, S. Q. (2026). Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review. Pain Management Nursing. https://doi.org/10.1016/j.pmn.2025.06.010
Vancouver
Jackson SB, Payton I, Powell-Roach K, Starkweather A, Cook RL, Varma DS, et al. Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review. Pain Management Nursing. 2026. doi:10.1016/j.pmn.2025.06.010
BibTeX
@article{Jackson2026,
author = {Jackson, Simone B and Payton, Isaac and Powell-Roach, Keesha and Starkweather, Angela and Cook, Robert L and Varma, Deepthi S and Terry, Ellen L and Booker, Staja Q},
title = {Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review},
journal = {Pain Management Nursing},
year = {2026},
doi = {10.1016/j.pmn.2025.06.010}
}
EUVIMED